Search results (31)
« Back to NewsDavid Church awarded a Cancer Research UK Senior Cancer Research Fellowship
25 March 2025
David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
At-home test could play key role in type-1 diabetes screening
17 February 2025
A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.
Bowel cancer prediction test for IBD patients 90% accurate
3 February 2025
Researchers in the CHG have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Oxford and GSK launch £50m programme to advance cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Toxic Cargoes Contributing to Dementia are Contained Within Extracellular Vesicles
17 January 2025
New research led by Dr Steph Fowler (UCL and now Oxford IMCM), Professor Karen Duff (UKDRI, UCL), with Dr Benjamin Ryskeldi-Falcon and Dr Tiana Behr (MRC LMB), have shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.
New blood test could enable early detection of multiple cancers
8 January 2025
A new blood test – powered by machine learning – has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics’ Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
DPhil student Grace Hood awarded Dr. Gregory D. Bossart Memorial One Health Scholarship 2024
13 November 2024
The $5000 Scholarship Award for 2024 was granted to Dr. Grace Hood for her One Health Project titled "Deforestation as a driver of emerging viral spillover events at the human-animal-environment interface in Malaysian Borneo"
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
22 October 2024
A pioneering study published in Nature Immunology offers unprecedented insights into cellular responses to common treatments, paving the way to transform the treatment landscape for these chronic inflammatory conditions.
Possible new transmission route for highly pathogenic avian influenza
17 October 2024
A new study published in Nature Communications has identified a new potential transmission route for H5 highly pathogenic avian influenza viruses (HPAI). Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.